SCHEMBL6565335

SCHEMBL6565335

COc1cc(-c2cncc(CN3CCCN(Cc4cncc(-c5cc(OC)c(OC)c(OC)c5)c4)CC3)c2)cc(OC)c1OC

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.56
TGFBR1 P36897 2/20 0.54
ACVR1 Q04771 2/20 0.54
POLB P06746 1/20 0.50
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
ALDH1A1 P00352 2/20 0.48
TDP1 Q9NUW8 1/20 0.48
ACVR1B P36896 1/20 0.47
DYRK1A Q13627 3/20 0.44
WNT1 P04628 2/20 0.44
DRD2 P14416 2/20 0.44
DRD4 P21917 2/20 0.44
DRD3 P35462 2/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
SLC29A1 Q99808 1/20 0.43
CYP2C9 P11712 1/20 0.43
ALOX15 P16050 1/20 0.43
TSHR P16473 1/20 0.43
CYP2C19 P33261 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5683737 0.96 TGFBR1 (0.57) KDM4ETGFBR1ACVR1POLBMEN1
Hydrochloric Acid SCHEMBL4772448 0.83 TGFBR1 (0.48) KDM4ETGFBR1ACVR1MEN1KMT2A
SCHEMBL5679807 0.81 KDM4E (0.61) KDM4ETGFBR1ACVR1POLBMEN1
SCHEMBL5683255 0.80 DRD4 (0.58) KDM4EPOLBMEN1KMT2AALDH1A1
SCHEMBL5679814 0.77 KDM4E (0.53) KDM4ETGFBR1ACVR1POLBMEN1
SCHEMBL13800772 0.76 BCHE (0.45) KDM4ETGFBR1ACVR1MEN1KMT2A
SCHEMBL13800339 0.76 CYP3A4 (0.42) TGFBR1ACVR1MEN1KMT2AALDH1A1
SCHEMBL4116108 0.76 CYP11B1 (0.55) KDM4ETGFBR1ACVR1ALDH1A1ACVR1B
SCHEMBL6568492 0.76 TGFBR1 (0.62) KDM4ETGFBR1ACVR1POLBMEN1
SCHEMBL4117618 0.76 FYN (0.45) KDM4ETGFBR1ACVR1POLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1403249-A1 CYCLIC DIAMINE COMPOUNDS BEARING SIX-MEMBERED CYCLIC GROUPS Kowa Co., Ltd. (JP) 2004-03-31 EP disclosed
US-6509329-B1 Inhibitory effects on both cell adhesion and cell infiltration and is useful as a medicine for prevention or treatment of diseases such as allergy, asthma, rheumatism, arteriosclerosis and inflammation KOWA CO., LTD. (JP) 2003-01-21 US disclosed